In a startling revelation that exposes the dark underbelly of Punjab's healthcare system, the Enforcement Directorate has launched a major investigation into 22 de-addiction centres operated by a single doctor across the state. The facilities, which were supposed to help people overcome addiction, are now under scrutiny for allegedly running a sophisticated pill trafficking operation.
The Double-Faced Operation
While presenting themselves as legitimate rehabilitation centres, these facilities are accused of systematically diverting pharmaceutical drugs meant for treatment into the open market. The ED's preliminary findings suggest that recovery medications were being sold through illegal channels, creating a dangerous cycle where treatment centres were potentially fueling the very addiction they claimed to combat.
Scale of the Alleged Fraud
The investigation spans multiple districts in Punjab, revealing an extensive network that allegedly operated under the guise of medical treatment. Sources indicate that the centres maintained dual records – one for official purposes showing legitimate medical use, and another tracking the illegal sale of controlled substances to black market operators.
How the Scheme Worked
- Centres obtained large quantities of pharmaceutical drugs under the pretext of patient treatment
- Medications meant for de-addiction therapy were systematically diverted
- Drugs were sold through established black market channels
- Financial transactions were allegedly routed through shell companies
Broader Implications for Punjab's Drug Crisis
This case strikes at the heart of Punjab's ongoing battle against drug addiction. The state, which has been grappling with a severe substance abuse problem, now faces the disturbing reality that some treatment centres might be part of the problem rather than the solution.
The ED's investigation is particularly significant given Punjab's sensitive position in India's drug epidemic. If proven true, these allegations represent a gross violation of medical ethics and a serious breach of public trust in healthcare institutions.
What's Next in the Investigation
Enforcement officials are currently examining financial records, patient admission data, and pharmaceutical procurement patterns across all 22 centres. The probe is expected to widen as investigators follow the money trail and identify all individuals involved in the alleged racket.
This case highlights the urgent need for stricter monitoring of de-addiction centres and better regulatory oversight of pharmaceutical distribution in sensitive healthcare sectors.
